The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man

Completed · Not applicable · Has a placebo group

Conditions studied: Obesity

In brief

The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.

Key facts

Study ID

NCT01710722

Run by

Pennington Biomedical Research Center

People needed

45

Starts

2001-02-01

Expected to finish

2002-02-01

Last updated by the study team

2015-12-18

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• You are healthy.
• You are not pregnant or nursing.
• You are between 18 and 60 years of age.
• You have a body mass index, calculated from your height and weight, of 30 to 40 kg/m2.

You may not qualify if…

• You take chronic medications except hormone replacement or contraception.
• You are a woman and are unwilling to use effective contraception during the trial.
• You have blood pressure higher than 150/90.
• You have heart disease.
• You have urinary symptoms from an enlarged prostate.
• You have gained or lost more than 10 pounds in the last 6 months.
• You have used a monoamine oxidase inhibitor medication in the last month.
• You have high or low thyroid function that has not been controlled in the normal range for at least 2 months.
• You have heart disease or a history of stroke.
• You have a known sensitivity to E. coli or E. coli derived products.

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.